A vaccine development and formulation technology company
vitrivaxbio.comLinkedInBoulder, ColoradoBiotech43 employees
16 sources · checked 1 time, last 22h ago
The source names Eli Lilly as participating and refers to other participants only as existing investors.
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series C | $87M | 2026-11-18 | F-Prime Capital, New Enterprise Associates, RA Capital Management, Sanofi Ventures | 14 outlets. #48 in Trending |
16 sources · checked 1 time, last 22h ago [ VERIFIED ] read against 1 of 16 sources The source names Eli Lilly as participating and refers to other participants only as existing investors. | ||||
VitriVax builds vaccine development and formulation technology for vaccine developers and public-health partners that aims to keep vaccines stable without refrigeration and deliver multiple doses in one shot.
VitriVax says its ALTA platform is designed to stabilize antigens and adjuvants, reduce cold-chain dependence, and release prime and booster doses from a single injection, addressing the distribution and adherence barriers that limit vaccination. Its oversubscribed $87 million Series C is intended to move a Lyme disease candidate into first-in-human trials and expand a proprietary vaccine pipeline, at a time when the company says there is no approved human Lyme vaccine and up to 50% of patients fail to complete rigorous multi-dose regimens.
Checked against 10 sources
| Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $17.3M | 2025-10-22 | Adjuvant Capital, RA Capital Management | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source
[ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: vitrivaxbio.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
Also named as backers in company research: Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), National Institutes of Health, State of Colorado, Defense Threat Reduction Agency (DTRA)